BackgroundPersonalized targeted therapies have transformed management of several solid tumors. Timely and accurate detection of clinically relevant genetic variants in tumor is central to the implemen
Shaded and non-shaded rows represent spiked (positive) and non-spiked (negative) samples, respectively; A–F represent coded identifiers of the six developers; the CDC used the Roche MagNaPure platform